Eurac Research
Bolzano, BZ, 39100, Italy
NCT Number: NCT04725539
Mountain sport activities as for example hiking or skiing may involve the risk of adverse health events especially in older people not accustomed to the specific mountain sport at altitude or people with pre-existing health issues. Increased activation of the sympathetic nervous system and abrupt changes in heart rate and blood pressure are thought to trigger these adverse effects. Preventive measures include regular physical activity (i.e. training) and adequate medical treatment. Hypoxia pre-adaptation (e.g., pre-adapt one night at moderate altitude) and pre-conditioning (e.g., intermittent hypoxia (IH) training), which was shown to lead to some favorable sympathetic nervous system, ventilatory and metabolic adaptations and additionally exerts anti-inflammatory action, could be hypothesized of being a further preventive measure. The aim of this research project is to investigate whether intermittent hypoxia pre-conditioning or sleeping one night at altitude (i.e., current recommendation before practicing mountain leisure sports in the elderly) is able to increase oxygen saturation during passive hypoxia exposure and during simulated hiking and skiing at altitude. Additionally, it is aimed to investigate whether such procedure reduces the physiological responses (i.e., heart rate, its variability and blood pressure (including baroreflex sensitivity) responses as well as metabolic, ventilatory, inflammatory and redox responses) during these activities.
Looking for future studies?
Notify Me50 year–70 year
All sexes
Interventional
Not applicable
Bolzano, BZ, 39100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of different hypoxic doses.
Intermittent hypoxia:
days 1-5 duration of breathing periods 5*3min (FiO2 14-21%) days 8-12 duration of breathing periods 4*4min (FiO2 = 12%) and 3*3 min (FiO2 = 21%) days 15-19 duration of breathing periods 5*5min (FiO2 = 10%) and 4*3 min (FiO2 = 21%)
one night at 1900m
Time frame: Through study completion, an average of 1.5 years
Resting oxygen saturation changes after the pre-conditioning and pre-adaptation program at 3000 m altitude
Time frame: Through study completion, an average of 1.5 years
Oxygen saturation during exercise changes after the pre-conditioning and pre-adaptation program at 3000 m altitude
Time frame: Through study completion, an average of 1.5 years
Heart rate response changes after the pre-conditioning and pre-adaptation program at rest and during exercise at 3000 m altitude.
Time frame: Through study completion, an average of 1.5 years
Blood pressure responses during rest and during exercise at altitude
Time frame: Through study completion, an average of 1.5 years
Inflammatory markers may change due to the programs
Time frame: Through study completion, an average of 1.5 years
Markers of physiological stress may change due to the programs
Time frame: Through study completion, an average of 1.5 years
HRV may change due to the programs
Time frame: Through study completion, an average of 1.5 years
BRS may change due to the programs
Time frame: Through study completion, an average of 1.5 years
Markers of myocardial injury may change due to the programs
Institute of Mountain Emergency Medicine
Other
Effects of Hypoxia Pre-conditioning on Physiological Responses During Mountain Sport Activities in Persons With a History of Coronary Artery Disease
Acronym: Hyx-PRE-Spo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00265525
Arterial Occlusive Diseases, Arteriosclerosis
London, Ontario, Canada
View Trial DetailsNCT07473596
Arterial Occlusive Diseases, Arteriosclerosis
Helsinki, Uusimaa, Finland
View Trial DetailsNCT05292092
Arterial Occlusive Diseases, Arteriosclerosis
Algeciras, Spain
View Trial DetailsNCT04936867
Arterial Occlusive Diseases, Arteriosclerosis
Frankfurt am Main, Hesse, Germany
View Trial Details